Current Research in Diabetes & Obesity Journal

Journal Information
EISSN : 2476-1435
Current Publisher: Juniper Publishers (10.19080)
Total articles ≅ 255
Filter:

Latest articles in this journal

Urbina Arronte Le, Villegas Narvaez Al, García-Ulloa Ac, Hernández Jiménez S, Vergara Juárez Jj
Current Research in Diabetes & Obesity Journal, Volume 13, pp 47-57; doi:10.19080/crdoj.2020.13.555870

Abstract:
In a comprehensive approach, patients with diabetes who have evidence of microvascular damage should be considered to have abnormalities in various systems. This can modulate the expected response to the prescription of physical activity and exercise.
Parmar Vinendra M
Current Research in Diabetes & Obesity Journal, Volume 13, pp 47-57; doi:10.19080/crdoj.2020.13.555869

Abstract:
The purpose of this study was to investigate the efficacy and safety of teneligliptin, a completely unique and highly selective DPP- 4 inhibitor in type 2 diabetes mellitus (T2DM) patients having dyslipidemia who are inadequately controlled by relevant conventional therapy in India.
Sanjeev Kumar, Kumari Shachi, Nayan Kumar Prasad
Current Research in Diabetes & Obesity Journal, Volume 13, pp 47-64; doi:10.19080/crdoj.2020.13.555868

Abstract:
Diabetes and cancer are most prevalent disease. Worldwide diabetes is the 4th leading cause of death in the most developed countries. Diabetes is a most common disease easily order affecting 285 million people throughout the world. From different observational studies suggested that diabetes and their allopathic medicines increase the risk of cancer malignancy. Herbal mediciene like- Diabecon Divyamadhunasanivati, IME-9 Madhurakshak Activ, Diacare reduce the blood glucose and No any side effects associated the use of these herbal drugs. Generally herbal Medicine making wellbeing of Patient and adding quality of life.
Fasiha Ahsan, Shahid Bashir, Faiz-Ul-Hassan Shah
Current Research in Diabetes & Obesity Journal, Volume 13, pp 47-53; doi:10.19080/crdoj.2020.13.555867

Abstract:
Researches on new molecules with the least toxic effects and better potency is on its way and more attention is being given upon medicinal plants for forcing away the above problems. Medicinal plants have been recognized as potential drug candidates. Stevia, a natural sweetener with medicinal properties and also having nutritional, therapeutic and industrial importance is being used all over the world. Stevia rebaudiana leaves are usually referred to as candy, sweet and honey leaves. Diterpene glycosides are responsible for its high sweetening potential of leaves. The phytochemical properties of bioactive chemicals present in stevia leaves are involves in maintaining the physiological functions of human body. Paper also highlights the importance of nutritional aspects of dried stevia leaves, metabolism of stevia, effects of it consumption on human health and clinical studies related to stevia ingestion. Various medicinal properties of stevia leaves discussed in paper like anti-hyperglycemia, anti-oxidative, hypotensive, nephro-protective, hepato protective, antibacterial and antifungal. Basic purpose of this review to understand the medicinal potential of stevia and its acceptance as a significant raw material for human diet.
Sikandar Hayat Khan, Farah Sobia, Rahat Shahid, Syed Ohen Raza Shah Bukhari, Syed Mohsin Manzoor, Roomana Anwar, Muhammad Tariq
Current Research in Diabetes & Obesity Journal, Volume 13, pp 38-46; doi:10.19080/crdoj.2020.13.555866

Abstract:
Low-density lipoprotein cholesterol (LDLc) remains a key lipid parameter and focus of clinical prevention targets for cardiovascular diseases. Although measured LDLc values are now available, many clinicians still rely on calculated method. Accordingly, several methods have evolved to overcome the shortcomings of previous models and improve risk prediction.
Current Research in Diabetes & Obesity Journal; doi:10.19080/crdoj

Abstract:
Current Research in Diabetes & Obesity Journal is an international peer reviewed Open Access journal of Juniper Publishers. CRDOJ is committed to increase knowledge, encouraging research and promoting better treatment for people suffering with Diabetes and Obesity.
Kristina Schmidt, Dirk Vetter, Katja Wagenblaß, Dominik Gartzke, Christoph Hasslacher, Martina Kraft, Nadine Matuszis, Usto Lorenzo Bermejo
Current Research in Diabetes & Obesity Journal, Volume 13, pp 6-8; doi:10.19080/crdoj.2020.13.555864

Abstract:
Satiolipid is a patented formulation composed of soluble, highly viscous plant fiber (hydroxypropylmethylcellulose) and lipids. We investigated the effects of Satiolipid administration to type 2 diabetes patients on diabetes-relevant metabolic parameters and weight.
Alanoud M Alobaidly, Wendy Abigail, Pauline Hill
Current Research in Diabetes & Obesity Journal, Volume 13, pp 6-11; doi:10.19080/crdoj.2020.13.555859

Abstract:
Kuwait ranks 8th in the prevalence of obesity and 9th in diabetes mellitus worldwide. Recently, physicians have introduced bariatric surgery as a treatment option for people with type 2 diabetes mellitus.
Sikandar Hayat Khan
Current Research in Diabetes & Obesity Journal, Volume 13, pp 6-11; doi:10.19080/crdoj.2020.13.555858

Abstract:
Since the 17th century when Thomas Willis described diabetic urine as “wonder Tolerance fully sweet” like sugar or honey, which paved way for future diagnostic methodologies for diabetes. Since then diabetes diagnostics over the last century had witnessed multi-step evolution from urine glucose analysis, to oral glucose tolerance test, and introduction of glycated hemoglobin. Urine glucose analysis by means of acid hydrolysis was started was introduced by Karl Trommer, in 1841, which is considered as a landmark milestone in the laboratory diagnostics [1].
Debmalya Sanyal, Soumyabrata Roy Chaudhuri, Somwrita Mitra
Current Research in Diabetes & Obesity Journal, Volume 13, pp 6-11; doi:10.19080/crdoj.2020.13.555857

Abstract:
Tea is one of the most widely consumed beverages in the world and is known for its high polyphenol content that has various health benefits. This investigation aims to study the potential of black tea compounds on subjects with new onset Type 2 diabetes mellitus. For this, 30 subjects with newly detected type 2 diabetes mellitus will be randomly enrolled into the study and will be advised to consume black tea on daily basis in a stipulated quantity. Anthropometric measurements, systolic and diastolic blood pressure, glycaemic and lipid profiles along with creatinine values will be analyzed during the study period. The effects of regular black tea consumption will then be assessed by observing the changes in the biochemical parameters at the end of the scheduled 12th week visit. A positive result will help us to popularise black tea as a safe as also a beneficial beverage for diabetic patients.
Back to Top Top